CIBC Private Wealth Group
ELTX icon

CIBC Private Wealth Group’s Elicio Therapeutics ELTX Stock Holding History

CIBC Private Wealth Group’s Portfolio ELTX Stock Details ELTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$55.7K Hold
7,000
– – ﹤0.01% 1736
2025
Q3 		$42.6K Hold
7,000
– – ﹤0.01% 1861
2025
Q2 		$42.6K Hold
7,000
– – ﹤0.01% 1730
2025
Q1 		$42.6K Hold
7,000
– – ﹤0.01% 1680
2024
Q4 		$42.6K Hold
7,000
– – ﹤0.01% 1735
2024
Q3 		$42.6K Hold
7,000
– – ﹤0.01% 1830
2024
Q2 		$42.6K Hold
7,000
– – ﹤0.01% 1735
2024
Q1 		$42.6K Buy
+7,000
New +$35.1K ﹤0.01% 1736

Other funds holding ELTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CIBC Private Wealth Group's ELTX Position: Q4 2025 in Review

CIBC Private Wealth Group held its Elicio Therapeutics (ELTX) position steady in Q4 2025 at 7,000 shares worth $55.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1736.

CIBC Private Wealth Group first reported a position in ELTX in Q1 2024 and has held it in 8 quarters since. 37 funds tracked by Wall St. Rank hold ELTX as of Q4 2025.

  • CIBC Private Wealth Group held 7,000 shares of Elicio Therapeutics worth $55.7K as of Q4 2025.
  • CIBC Private Wealth Group left its Elicio Therapeutics share count unchanged in Q4 2025.
  • Elicio Therapeutics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1736 holding.
  • CIBC Private Wealth Group first reported a position in Elicio Therapeutics in Q1 2024 and has held it in 8 quarters since.
  • 37 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.